TRIM22 and hepatocellular carcinoma: Even in the six HCC patients with elevated AFP levels, Trim22 mRNA analysis revealed decreased expression in the tumor compared to the background non-tumor in five of the six patients (83.3%) and most of these patients (4/5) had Trim22 mRNA levels less than 0.5.